Qiming Venture Partners Wishes You a Prosperous Start to the Work Year
Spring breezes follow the measure; great ventures grow newer by the day.
The eighth day of the first lunar month — a new journey begins
Qiming Venture Partners wishes you favorable winds and thriving enterprise
Long-press to save the two posters below
Feel free to share!
Poster 1: Steeds Herald Spring
Poster 2: Fortune's Dawn
Previously
Five AI IPOs in Seven Months, Qiming Venture Partners: Investing in AI Is the Greatest Certainty in Chinese Investing Over the Next Two Decades Red Packets Incoming | Qiming Venture Partners' Limited-Edition Year of the Horse Red Packet Covers Qiming Honors | Five Qiming Venture Partners Investors Named to 2025 Forbes China Midas List
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management of $9.5 billion. Since its inception, the firm has focused on investing in outstanding early- and growth-stage companies in technology and healthcare innovation.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative enterprises. More than 210 of these have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. Over 80 portfolio companies have become recognized unicorns or super-unicorns.
Many Qiming Venture Partners portfolio companies have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), Hesai Technology (NASDAQ:HSAI, 02525.HK), UBTECH (09880.HK), WeRide (NASDAQ:WRD, 00800.HK), HyperStrong (688411.SH), Insta360 (688775.SH), Unisound (09678.HK), Biren Technology (06082.HK), Zhipu (02513.HK), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), SinocellTech (688520.SH), Insilico Medicine (03696.HK), Argo Biopharma, Yuanxin Technology, MediLink Therapeutics, LaNova Medicines, StepFun, and others.